Rhaponticin suppresses osteosarcoma through the inhibition of PI3K-Akt-mTOR pathway-Reference-Cited by-同舟云学术

Rhaponticin suppresses osteosarcoma through the inhibition of PI3K-Akt-mTOR pathway

Published:2021-07 Issue:7 Volume:28 Page:3641-3649
ISSN:1319-562X
Container-title:Saudi Journal of Biological Sciences
language:en
Short-container-title:Saudi Journal of Biological Sciences

Author:

Mickymaray Suresh^ORCID,Alfaiz Faiz Abdulaziz,Paramasivam Anand^ORCID,Veeraraghavan Vishnu Priya,Periadurai Nanthini Devi,Surapaneni Krishna Mohan,Niu Guangfeng

Publisher

Elsevier BV

Subject

General Agricultural and Biological Sciences

Reference59 articles.

1. Anti-fungal efficacy and mechanisms of flavonoids;Aboody;Antibiotics (Basel),2020

2. Transcriptomics-based characterization of the toxicity of ZnO nanoparticles against chronic myeloid leukemia cells;Alsagaby;Int. J. Nanomed.,2020

3. High–BMI at diagnosis is associated with inferior survival in patients with osteosarcoma: A report from the children's oncology group;Altaf;Pediatr. Blood Cancer,2013

4. Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma;Bernthal;Cancer,2012

5. Inhibiting the PI3K/AKT/mTOR signalling pathway with copper oxide nanoparticles from Houttuynia cordata plant: attenuating the proliferation of cervical cancer cells;Chen;Artif. Cells Nanomed. Biotechnol.,2021

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Inhibition of the PI3K/Akt/mTOR Signaling Axis: Potential for Sarcoma Therapy;Mini-Reviews in Medicinal Chemistry;2024-09

2. Enhancing Therapeutic Efficacy in Cancer Treatment: Integrating Nanomedicine with Autophagy Inhibition Strategies;ACS Omega;2024-06-18

3. Mefenamic acid exhibits antitumor activity against osteosarcoma by impeding cell growth and prompting apoptosis in human osteosarcoma cells and xenograft mice model;Chemico-Biological Interactions;2024-04

4. Effect of traditional Chinese medicine in osteosarcoma: Cross-interference of signaling pathways and potential therapeutic targets;Medicine;2024-01-19

5. Proteomics and genomics insights on malignant osteosarcoma;Functional Proteomics;2024